Pseudotyped retrovirus with modified ebola glycoprotein
US7981656B2 · kind B2 · utility
0Cited by
16References
7Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 4, 2003 |
| Grant date | Jul 19, 2011 |
| Priority date | — |
| Expiry date | Nov 19, 2026 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S977/803
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Pseudotyped retroviruses having viral glycoproteins with modified O glycosylation regions are provided. Also provided are methods for making the pseudotyped retroviruses of the present invention and for using the pseudotyped retroviruses for transduction of target cells. Cells for stably producing the pseudotyped retroviruses or the present invention are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.